• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性痴呆和阿尔茨海默病——我们是否走入了死胡同?

Vascular dementia and Alzheimer's disease - are we in a dead-end road?

机构信息

Division of Special Neurology, Department of Neurology, Medical University of Graz, Graz, Austria.

出版信息

Neurodegener Dis. 2010;7(1-3):122-6. doi: 10.1159/000285521. Epub 2010 Feb 18.

DOI:10.1159/000285521
PMID:20173341
Abstract

BACKGROUND

Diagnostic criteria separating vascular dementia from other dementias, particularly Alzheimer's disease (AD) neglect the real world in which most AD cases present with at least some vascular brain lesions. Most importantly, vascular lesions, even if subtle, exert significant effects on the patients' cognitive functioning if they coexist with AD pathology.

OBJECTIVES

To emphasize the need for an integrative dementia concept in which the vascular component represents an important end point in trial planning and a possibility for disease modification along the whole spectrum of combined vascular and primary degenerative pathology.

METHODS

Review of the literature on possible surrogate markers to study the contribution of vascular brain damage in dementia.

RESULTS

The longitudinal change in volume of white matter lesions is the best elaborated putative surrogate marker for the study of the vascular component in dementia. Validation of the role of lacunes and microbleeds as surrogate end points is poor. Loss of brain volume is an important adjunct outcome measure even though the vascular origin of atrophy remains uncertain.

CONCLUSIONS

A focus on pure vascular dementia distracts from the importance of vascular factors in dementia. Consideration of the vascular component in future clinical trials will improve our pathophysiological understanding and provide options for treatment.

摘要

背景

将血管性痴呆与其他类型痴呆(尤其是阿尔茨海默病,AD)区分开来的诊断标准忽略了大多数 AD 患者至少存在一些血管性脑损伤的现实世界。最重要的是,如果血管性病变与 AD 病理学共存,即使是轻微的病变也会对患者的认知功能产生重大影响。

目的

强调需要一种综合的痴呆概念,其中血管成分代表了试验计划中的一个重要终点,并且有可能沿着血管性和原发性退行性病变的整个谱系进行疾病修饰。

方法

对可能的替代标志物进行文献回顾,以研究血管性脑损伤在痴呆中的作用。

结果

脑白质病变体积的纵向变化是研究痴呆中血管成分的最佳替代标志物。腔隙和微出血作为替代终点的验证效果较差。脑容量的丧失是一个重要的附加结果测量指标,尽管脑萎缩的血管起源仍不确定。

结论

关注单纯的血管性痴呆会忽略血管因素在痴呆中的重要性。在未来的临床试验中考虑血管成分将提高我们的病理生理学理解,并提供治疗选择。

相似文献

1
Vascular dementia and Alzheimer's disease - are we in a dead-end road?血管性痴呆和阿尔茨海默病——我们是否走入了死胡同?
Neurodegener Dis. 2010;7(1-3):122-6. doi: 10.1159/000285521. Epub 2010 Feb 18.
2
Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.心血管健康研究认知研究中血管性痴呆的分类
Neurology. 2005 May 10;64(9):1539-47. doi: 10.1212/01.WNL.0000159860.19413.C4.
3
Identification of Alzheimer and vascular lesion thresholds for mixed dementia.混合性痴呆中阿尔茨海默病和血管病变阈值的鉴定。
Brain. 2007 Nov;130(Pt 11):2830-6. doi: 10.1093/brain/awm228. Epub 2007 Sep 18.
4
Modern concept of vascular cognitive impairment.血管性认知障碍的现代概念。
Br Med Bull. 2007;83:291-305. doi: 10.1093/bmb/ldm021. Epub 2007 Aug 4.
5
Pathology and pathophysiology of vascular cognitive impairment. A critical update.血管性认知障碍的病理学与病理生理学。重要更新。
Panminerva Med. 2004 Dec;46(4):217-26.
6
Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.阿尔茨海默病和非阿尔茨海默病性痴呆中步态障碍的患病率和严重程度。
J Am Geriatr Soc. 2005 Oct;53(10):1681-7. doi: 10.1111/j.1532-5415.2005.53552.x.
7
The enigma of vascular cognitive disorder and vascular dementia.血管性认知障碍和血管性痴呆之谜。
Acta Neuropathol. 2007 Apr;113(4):349-88. doi: 10.1007/s00401-006-0185-2. Epub 2007 Feb 7.
8
Facts, myths, and controversies in vascular dementia.血管性痴呆中的事实、误解与争议
J Neurol Sci. 2004 Nov 15;226(1-2):49-52. doi: 10.1016/j.jns.2004.09.011.
9
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience.评估阿尔茨海默病病理学和血管负荷对衰老大脑的认知影响:日内瓦的经验。
Acta Neuropathol. 2007 Jan;113(1):1-12. doi: 10.1007/s00401-006-0144-y. Epub 2006 Oct 12.
10
[Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?].[磁化传递率(MTR)对痴呆症的诊断和鉴别诊断有帮助吗?]
Rofo. 2004 Dec;176(12):1743-9. doi: 10.1055/s-2004-813650.

引用本文的文献

1
Detection of subtle white matter lesions in MRI through texture feature extraction and boundary delineation using an embedded clustering strategy.通过纹理特征提取和边界描绘的嵌入式聚类策略在 MRI 中检测细微的脑白质病变。
Sci Rep. 2022 Mar 15;12(1):4433. doi: 10.1038/s41598-022-07843-8.
2
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia.脑脊液载脂蛋白 L2 作为血管性痴呆鉴别诊断的新型生物标志物。
Nat Commun. 2020 Jan 30;11(1):619. doi: 10.1038/s41467-020-14373-2.
3
Cognitive profiles in degenerative dementia without evidence of small vessel pathology and small vessel vascular dementia.
无小血管病变证据的退行性痴呆和小血管性血管性痴呆的认知特征。
Neurol Sci. 2017 Jan;38(1):101-107. doi: 10.1007/s10072-016-2716-5. Epub 2016 Sep 21.
4
Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population.皮质浅表性铁沉积症:记忆门诊人群中的患病率及生物标志物特征
Neurology. 2016 Sep 13;87(11):1110-7. doi: 10.1212/WNL.0000000000003088. Epub 2016 Aug 17.
5
Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment.在认知障碍连续体中,随着脑微出血数量增加的脑脊液特征。
J Cereb Blood Flow Metab. 2016 Mar;36(3):621-8. doi: 10.1177/0271678X15606141. Epub 2015 Sep 30.
6
Cerebral small vessel disease, cognitive reserve and cognitive dysfunction.脑小血管病、认知储备与认知功能障碍
J Neurol. 2015 Nov;262(11):2411-9. doi: 10.1007/s00415-015-7776-6. Epub 2015 May 16.
7
CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease.脑小血管病患者的脑脊液生物标志物与神经心理学特征
PLoS One. 2014 Aug 22;9(8):e105000. doi: 10.1371/journal.pone.0105000. eCollection 2014.
8
Vascular disease and dementias: paradigm shifts to drive research in new directions.血管疾病与痴呆:范式转变推动新方向的研究。
Alzheimers Dement. 2013 Jan;9(1):76-92. doi: 10.1016/j.jalz.2012.02.007. Epub 2012 Nov 22.
9
Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease.载脂蛋白A1的多态性影响高密度脂蛋白胆固醇水平,但并非阿尔茨海默病的主要危险因素。
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):249-57. doi: 10.1159/000329910. Epub 2012 Jan 17.
10
CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques.CLU、CR1 和 PICALM 基因与阿尔茨海默病相关的老年斑有关。
Alzheimers Res Ther. 2011 Apr 5;3(2):12. doi: 10.1186/alzrt71.